Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Ipilimumab plus nivolumab elicits response in patients with rare cancer

Combination treatment with ipilimumab and nivolumab yields meaningful response among patients with multiple refractory rare cancer types, according to a phase II trial.

Ipilimumab plus nivolumab elicits response in patients with rare cancer

9 giờ trước

Inhaled levodopa helps manage off episodes in PD, regardless of age

một ngày trước bởi

Treatment with the inhaled levodopa formulation CVT-301 provides rapid motor symptom relief during off periods, with consistent efficacy seen across Parkinson’s disease (PD) patients of all ages, according to a post hoc analysis of three phase III trials.

Inhaled levodopa helps manage off episodes in PD, regardless of age

một ngày trước

Updated PREDICT model identifies low-risk TNBC patients who can skip chemo

một ngày trước

The addition of stromal tumour-infiltrating lymphocytes (sTILs) to the PREDICT prognostic model further improves decision-making regarding chemotherapy for early-stage patients with triple-negative breast cancer (TNBC), particularly in identifying those at low risk who may safely waive chemotherapy, according to a study.

Updated PREDICT model identifies low-risk TNBC patients who can skip chemo

một ngày trước

8-strain probiotic formulation promising for bile acid malabsorption

một ngày trước

The De Simone formulation 8-strain probiotic appears to induce favourable microbiome and metabolome changes in patients with bile acid malabsorption, as shown in a study.

8-strain probiotic formulation promising for bile acid malabsorption

một ngày trước

Acute HF patients with frailty respond favourably to SGLT2 inhibitor therapy

08 Aug 2026 bởi

Initiation of sodium–glucose cotransporter‐2 (SGLT2) inhibitor therapy upon hospital discharge is associated with improved clinical outcomes among patients with acute heart failure (HF), especially those with frailty, according to the West Tokyo Heart Failure 2 (WET‐HF 2) registry in Japan.

Acute HF patients with frailty respond favourably to SGLT2 inhibitor therapy

08 Aug 2026

Vaginal tamoxifen beneficial to postmenopausal women

08 Aug 2026

In postmenopausal women with or without breast cancer, once-weekly treatment with vaginal tamoxifen helps reduce anxiety symptoms and relieve pain, as shown in a study.

Vaginal tamoxifen beneficial to postmenopausal women

08 Aug 2026

Tau-targeting therapy for early AD gets a pass to phase III

07 Aug 2026 bởi

In the phase II CELIA trial, the investigational tau-targeting antisense oligonucleotide (ASO) diranersen has shown therapeutic potential in patients with early Alzheimer’s disease (AD), yielding substantial reductions in tau burden and slowing clinical decline despite missing its primary endpoint.

Tau-targeting therapy for early AD gets a pass to phase III

07 Aug 2026

Simvastatin extends survival in patients with cirrhosis after variceal bleed

07 Aug 2026

Treatment with simvastatin appears to improve survival in some patients with cirrhosis after variceal bleed, suggests a study. The drug also reduces the incidence of new-onset, refractory ascites and its complications.

Simvastatin extends survival in patients with cirrhosis after variceal bleed

07 Aug 2026

Oral PPI mitigates delayed bleeding in G-ESD, G-EMR

07 Aug 2026 bởi

Oral administration of proton-pump inhibitor (PPI) helps reduce the risk of delayed bleeding in gastric endoscopic mucosal resection (G-EMR) and gastric endoscopic submucosal dissection (G-ESD) but not in esophageal endoscopic mucosal resection (E-EMR), esophageal endoscopic submucosal dissection (E-ESD), and percutaneous endoscopic gastrostomy (PEG), according to a study.

Oral PPI mitigates delayed bleeding in G-ESD, G-EMR

07 Aug 2026

Interruptions in chemotherapy does not cut survival in patients with cervical cancer

07 Aug 2026

Intercycle delays in first-line systemic chemotherapy do not appear to negatively affect survival among patients with metastatic or recurrent cervical cancer, reveals a study.

Interruptions in chemotherapy does not cut survival in patients with cervical cancer

07 Aug 2026

Tin tức & Cập nhật

Xem bài viết Dược

Xem

Chuyên ngành:

Ipilimumab plus nivolumab elicits response in patients with rare cancer

Ipilimumab plus nivolumab elicits response in patients with rare cancer

Inhaled levodopa helps manage off episodes in PD, regardless of age

Inhaled levodopa helps manage off episodes in PD, regardless of age

Updated PREDICT model identifies low-risk TNBC patients who can skip chemo

Updated PREDICT model identifies low-risk TNBC patients who can skip chemo

8-strain probiotic formulation promising for bile acid malabsorption

8-strain probiotic formulation promising for bile acid malabsorption

Acute HF patients with frailty respond favourably to SGLT2 inhibitor therapy

Acute HF patients with frailty respond favourably to SGLT2 inhibitor therapy

Vaginal tamoxifen beneficial to postmenopausal women

Vaginal tamoxifen beneficial to postmenopausal women

Tau-targeting therapy for early AD gets a pass to phase III

Tau-targeting therapy for early AD gets a pass to phase III

Simvastatin extends survival in patients with cirrhosis after variceal bleed

Simvastatin extends survival in patients with cirrhosis after variceal bleed

Oral PPI mitigates delayed bleeding in G-ESD, G-EMR

Oral PPI mitigates delayed bleeding in G-ESD, G-EMR

Interruptions in chemotherapy does not cut survival in patients with cervical cancer

Interruptions in chemotherapy does not cut survival in patients with cervical cancer